63 studies found for:    Open Studies | "Diabetic Nephropathies"
Show Display Options
Rank Status Study
21 Recruiting Study of LY3016859 in Participants With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Placebo;   Drug: LY3016859
22 Recruiting Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Beraprost sodium
23 Recruiting Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Conditions: Kidney Diseases;   Kidney Failure, Chronic;   Diabetic Nephropathy;   Lupus Nephritis;   Glomerulonephritis, IGA
Intervention:
24 Unknown  Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy
Conditions: Type 2 Diabetes Mellitus;   Diabetic Nephropathy
Interventions: Drug: ACE inhibitors,ARB, HMG-CoA reductase inhibitors, vitamins;   Behavioral: Compliance, antismoking, and nutrition instruction
25 Recruiting Impact of a Multidisciplinary Self-care Management Program on Quality of Life, Self-care Behavior, Adherence to the Anti-hypertensive Treatment, Glycemic Control, and Renal Function in Adults Living With Diabetic Kidney Disease
Condition: Diabetic Kidney Disease
Intervention: Behavioral: Self-care management program
26 Recruiting Efficacy, Safety, and Tolerability of GS-4997 in Participants With Diabetic Kidney Disease
Condition: Diabetic Kidney Disease
Interventions: Drug: GS-4997;   Drug: Placebo to match GS-4997
27 Recruiting Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy.
Conditions: Diabetic Nephropathy;   Hypertension
Intervention: Drug: Green tea extract
28 Recruiting Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease
Condition: Diabetic Nephropathies
Interventions: Drug: Moxonidine;   Drug: Placebo
29 Recruiting Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Probucol 250mg/day;   Drug: Probucol 500mg/day;   Drug: Placebo
30 Recruiting Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Calcitriol;   Drug: Placebo
31 Unknown  Impact of Vitamin D on Diabetic Kidney Disease in African Americans
Condition: Diabetic Kidney Disease
Intervention: Drug: Vitamin D3
32 Recruiting Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD)
Conditions: Diabetes;   Hypertension;   Diabetic Kidney Disease
Intervention: Behavioral: Pharmacist  telehealth intervention
33 Recruiting The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease
Condition: Diabetic Kidney Disease
Intervention: Drug: Liraglutide
34 Recruiting Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients.
Conditions: Type 2 Diabetes;   Diabetic Nephropathy;   Hypertension;   Sleep Apnea
Interventions: Device: NCPAP; Nasal continuous positive airway pressure.;   Device: NCPAP Nasal Continuous Positive Airway Pressure-sub-therapeutic treatment group
35 Recruiting Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease
Condition: Diabetic Kidney Disease
Interventions: Drug: BMS-813160;   Drug: Placebo matching with BMS-813160
36 Recruiting Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
Conditions: Diabetic Nephropathy;   Diabetes Mellitus;   Diabetic Kidney Disease;   Albuminuria
Intervention:
37 Unknown  Immunosuppression Impact on the Metabolic Control of First Kidney Transplant Recipients With Pre-Existing Type 2 Diabetes (DM)
Conditions: Kidney Transplant;   Diabetes Mellitus, Type 2;   Diabetic Nephropathy
Interventions: Drug: Cyclosporin;   Drug: Tacrolimus;   Behavioral: Diabetes Education / Management
38 Unknown  A Trial in Adults With Type 1 Diabetes Mellitus Evaluating the Effects of Fenofibrate Versus Placebo on Macular Thickness and Volume
Conditions: Type 1 Diabetes Mellitus;   Retinopathy;   Diabetic Nephropathy
Interventions: Drug: Fenofibrate;   Drug: Inert lactose placebo
39 Recruiting A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: PF-04634817;   Drug: Placebo
40 Recruiting Arterial Stiffness and Complication Risk in Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Diabetes Complications;   Diabetic Angiopathies;   Diabetic Nephropathies
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years